Anterra Capital reached a $100 million first close for its third fund, aiming for a final total of $200 million, with support from Rabobank, Novo Holdings, and Zoetis.
Over the last 12 years, the firm has prioritised strong business fundamentals over passing trends such as quick commerce, indoor vertical farming, or alternative proteins, a strategy that led to a major early-stage exit in the veterinary sector.
Recognising that AI is reshaping the financial landscapes of biology and software, Anterra identifies significant potential in the $10 trillion food and agriculture industry, which remains largely underserved by software solutions.
Most venture firms see their investors mainly as sources of money. Anterra Capital, however, treats its investors as a key part of its operations.
The VC firm, which has offices in Amsterdam and Boston, closed the first part of its third fund at $100 million and aims for $200 million at final close. The main investors are Rabobank, the world’s largest agricultural lender; Novo Holdings, a top global life sciences investor; and Zoetis, the largest animal health company.
